September 9, 2025
Title: Fit-for-Purpose RWD: An Integral Part of Evidence Planning
Tuesday, September 9, 2025
11:00AM EDT | 5:00PM UTC | 7:00PM CEST
Click here for time zone conversion
Registration coming soon
Description
Evidence planners across the life sciences industry—including Integrated Evidence Planning teams, HEOR and Market Access teams, Clinical Development, Epidemiology and Safety, and Medical Affairs—are increasingly adopting Integrated Evidence Planning (IEP) to address the diverse and evolving evidence requirements of multiple stakeholders throughout the asset lifecycle. Real-world evidence (RWE) is one of the most critical components of the IEP, aimed at demonstrating the safety, effectiveness, and value of pharmaceutical/biotech products beyond traditional clinical trials. At the same time, there has been an evolution and emergence of new data sources globally, encompassing various types of data sources, i.e., patient registries, chart abstraction, patient surveys, electronic health records, claims (open and closed), billing, lab, genomic and molecular data, and patient-generated data from wearables and mobile apps, plus any combination thereof. Although this data has greatly expanded our ability to generate RWE, navigating this continuously evolving landscape and ensuring selection of the appropriate real-world data (RWD) sources to address the research objective during the evidence planning phase is becoming more complex.
This webinar will explore the expanding portfolio of RWD sources across a spectrum of landscapes, including US (advanced landscape), Europe (evolving landscape) and other countries (emerging landscapes). We will discuss some of the challenges with planning and designing RWE studies and aim to provide a guiding framework to develop study concepts with a high probability of success. A key focus will be on practical strategies for selecting the right data to meet specific research needs, whether it is to evaluate safety, understand healthcare utilization or assess treatment adherence. We will also address critical considerations regarding data quality, completeness, representativeness, and regulatory compliance that impact the integrity and usability of the data to ensure successful implementation of RWE generation.
Learning Objectives
- Understand the evolving RWE landscape and key data sources.
- Assess ‘fit-for-purpose’ RWD.
- Examine common limitations of using RWD and ways to solve them.
Moderator:
Dana Stafkey, PharmD, PhD, Vice President, Real-World Evidence, Cencora, Raleigh-Durham, NC, USA
Speaker:
Tasneem Lokhandwala, PhD, Senior Director, Real-World Evidence, Cencora, Key Largo, FL, USA
Sponsored by Corporate Partner, Cencora
Please note: On the day of the scheduled webinar, the first 1000 registered participants will be accepted into the webinar. For those who are unable to attend, or would like to review the webinar at a later date, the full-length webinar recording will be made available at the ISPOR Educational Webinar Series webpage approximately 2 days after the scheduled Webinar. Reservations are on a first-come, first-served basis.